Purchase Order 75N93022P00432
Award Date
3/7/22
Potential Completion Date
3/6/25
Potential Value
$169K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Bio-Active Company LIMITED
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambodia
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $47,610.00 firm fixed price purchase order to Bio-Active Company LIMITED, a for-profit limited liability company in Thailand. The contract is for an annual maintenance agreement to support the NIAID's Illumina NextSeq 2000 genetic sequencing system in Cambodia. This award is not associated with a larger contract vehicle. No set-aside designations were used. Bio-Active Company LIMITED has previously...
This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The $102,468 contract is for preventive maintenance services on an Illumina MiSeq genetic sequencing system operated by the Naval Medical Research Unit 2 (NAMRU-2) laboratory in Cambodia. The contract has a completion date of March 7, 2020 and was awarded on March 3, 2017. No set-aside provisions were...
This is a firm fixed price purchase order awarded by the U.S. Department of Defense's Bureau of Medicine and Surgery (BUMED) to Bio-Active Company Limited, a for-profit limited liability company based in Thailand. The contract, valued at $81,605.50, is for preventive maintenance services on an Illumina MiSeq genetic sequencing system located at the U.S. Naval Medical Research Unit-2 (NAMRU-2) facility in Cambodia. The contract was competitively awarded and does not have a set-aside...
This is a firm fixed price contract awarded by the Office of Intergovernmental and External Affairs, a civilian agency, to Bio-Active Company LIMITED, a for-profit limited liability company, to provide services on the Illumina MiSeq genetic sequencing system. The contract has a ceiling value of $27,212.02 and a period of performance through August 31, 2025. This is a call order issued against a previously established Blanket Purchase Agreement held by Bio-Active Company LIMITED to provide...
This is a firm fixed price contract awarded to Bio-Active Company LIMITED, a for-profit limited liability company, by the U.S. Department of Defense's Medical Command (MEDCOM). The contract provides for services related to the operation and maintenance of Illumina MiSeq genetic sequencing systems used to support infectious disease monitoring and research in Thailand. The award, valued at $27,615.93, is a call against a previously established Blanket Purchase Agreement between Bio-Active...
The Defense Intelligence Agency awarded a firm fixed price purchase order for $29,116 to Bio-Active Company LIMITED to provide maintenance support for one Illumina MiSeq next generation sequencing system located in Thailand. The order was issued against a blanket purchase agreement held by Bio-Active Company LIMITED to provide sequencing services and instrument sustainment to multiple U.S. agencies in Thailand, including the Department of Defense, Army Medical Command, and Centers for Disease...
This firm fixed price contract was awarded to Bio-Active Company LIMITED, a for-profit limited liability company, to provide services on the Illumina MiSeq sequencing system. The $27,344.86 contract is a call against a previously awarded Blanket Purchase Agreement to support infectious disease monitoring and research conducted by U.S. government health agencies, including the Centers for Disease Control and Prevention (CDC), operating programs in Thailand. No set-aside was used for this award....
This is a firm fixed price contract awarded by the Office of the Secretary of Defense to Bio-Active Company LIMITED, a for-profit limited liability company, to provide maintenance and emergency services for an Illumina MiSeq genetic sequencing instrument located in Thailand. The contract, valued at $29,088.00, is a call against a pre-existing Blanket Purchase Agreement to support infectious disease monitoring and research efforts by various U.S. government agencies, including the Centers for...
This is a firm fixed price purchase order awarded by the Chief of Naval Operations (CNO), a Defense agency, to Bio-Active Company LIMITED, a for-profit limited liability company. The contract is to provide Illumina sequencing systems, reagents, and testing materials to support infectious disease monitoring and research conducted by the U.S. government in Thailand. The total ceiling value of the purchase order is $35,043.75, and the period of performance runs through May 2, 2023. This award...
This is a $19,000 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Dksh (Cambodia) LIMITED, a for-profit limited liability company. The contract is for 1 year of preventive maintenance on a BD FACSSymphony A1 flow cytometer, including comprehensive service and laser coverage, for use in NIAID operations in Cambodia. The contract does not have a set-aside...